Angelique received her B.S. in psychology in 2010 and her M.S. in neuroscience with a specialization in neurodegeneration in 2012 at King’s College London, England. She worked under the guidance of Dr. Frank Hirth investigating the effects of TDP-43 on Excitatory Amino Acid Transporter 1 (EAAT1) using a transgenic drosophila model of TDP-43 related ALS. In 2013 she started her Ph.D. work in Biomedicine at the University of Barcelona, Spain and joined Dr. Antonella Consiglio’s laboratory. Her thesis focused on evaluating the glial contributions to Parkinson’s disease (PD) pathogenesis using induced pluripotent stem cells (iPSC). She was awarded her Ph.D. in 2017 and joined the Croft group at NYSCF as a Postdoctoral Fellow in January of 2019 until March 2021. She was focused on investigating the pathogenic mechanisms in PD astrocytes, as well as microglia and their effect on dopaminergic neurons using a combination of 2D and 3D organoid cell culture models, analyzing with non-biased automated analysis softwares (imaris, metamorph, harmony). She is now an Assistant Professor at University California, San Francisco working at the Institute of Neurodegenerative diseases (IND) under the guidance of Nobel laureate Stanley B. Prusiner focused on tau prionopathy.